Better Buy: Gilead Sciences vs. Pfizer
If you're looking for solid dividend stocks, big drugmakers are a good place to start. And among the big drug stocks, few offer dividends as attractive as those of Gilead Sciences (NASDAQ: GILD) and Pfizer (NYSE: PFE).
Of course, in buying stocks, there's more to the story than just dividends. With drugmakers, you need to look at the strength of their current product lineups and the potential for their pipelines as well. Which of these two drug stocks is the better pick for long-term investors? Here are the top arguments for both Gilead and Pfizer.
Image source: Getty Images.
Source Fool.com
